ClariVest Asset Management LLC cut its position in shares of Amsurg Corp. (NASDAQ:AMSG) by 9.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 49,147 shares of the company’s stock after selling 5,302 shares during the period. ClariVest Asset Management LLC’s holdings in Amsurg Corp. were worth $3,810,000 at the end of the most recent quarter.
A number of other hedge funds also recently modified their holdings of the stock. Smith Asset Management Group LP increased its stake in shares of Amsurg Corp. by 8,500.0% in the second quarter. Smith Asset Management Group LP now owns 1,720 shares of the company’s stock worth $133,000 after buying an additional 1,700 shares during the period. Invictus RG increased its stake in shares of Amsurg Corp. by 824.3% in the first quarter. Invictus RG now owns 1,904 shares of the company’s stock worth $142,000 after buying an additional 1,698 shares during the period. Checchi Capital Advisers LLC bought a new stake in shares of Amsurg Corp. during the second quarter worth $157,000. Oakbrook Investments LLC bought a new stake in shares of Amsurg Corp. during the second quarter worth $209,000. Finally, Mount Lucas Management LP increased its stake in shares of Amsurg Corp. by 10.3% in the first quarter. Mount Lucas Management LP now owns 3,483 shares of the company’s stock worth $260,000 after buying an additional 326 shares during the period. 98.42% of the stock is owned by hedge funds and other institutional investors.
Amsurg Corp. (NASDAQ:AMSG) traded down 0.72% during midday trading on Friday, reaching $66.03. 994,485 shares of the company’s stock traded hands. The stock has a 50-day moving average of $65.63 and a 200 day moving average of $73.31. The company has a market cap of $3.55 billion, a P/E ratio of 19.59 and a beta of 0.68. Amsurg Corp. has a 52-week low of $58.37 and a 52-week high of $87.29.
Amsurg Corp. (NASDAQ:AMSG) last released its quarterly earnings data on Tuesday, August 2nd. The company reported $1.10 EPS for the quarter, topping the Zacks’ consensus estimate of $1.08 by $0.02. Amsurg Corp. had a net margin of 6.53% and a return on equity of 8.20%. The firm earned $758.50 million during the quarter, compared to analysts’ expectations of $769.88 million. During the same period in the previous year, the business posted $0.97 earnings per share. The company’s revenue for the quarter was up 21.5% compared to the same quarter last year. On average, analysts anticipate that Amsurg Corp. will post $4.33 earnings per share for the current fiscal year.
AMSG has been the subject of a number of recent research reports. Zacks Investment Research upgraded shares of Amsurg Corp. from a “hold” rating to a “buy” rating and set a $88.00 price objective for the company in a research note on Monday, July 11th. Goldman Sachs Group Inc. restated a “buy” rating on shares of Amsurg Corp. in a research note on Friday, June 17th. Robert W. Baird restated a “buy” rating on shares of Amsurg Corp. in a research note on Thursday, June 16th. Cantor Fitzgerald restated a “buy” rating and issued a $95.00 price objective on shares of Amsurg Corp. in a research note on Thursday, July 14th. Finally, Mizuho increased their price objective on shares of Amsurg Corp. from $90.00 to $95.00 and gave the company a “buy” rating in a research note on Friday, June 24th. Three analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $92.09.
In other Amsurg Corp. news, insider Robert Jon Coward sold 7,500 shares of Amsurg Corp. stock in a transaction on Friday, August 26th. The shares were sold at an average price of $63.65, for a total transaction of $477,375.00. Following the completion of the transaction, the insider now directly owns 97,507 shares of the company’s stock, valued at $6,206,320.55. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 2.30% of the company’s stock.
Amsurg Corp. Company Profile
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Want to see what other hedge funds are holding AMSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amsurg Corp. (NASDAQ:AMSG).
Receive News & Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related companies with MarketBeat.com's FREE daily email newsletter.